nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—AR—gestational diabetes	0.967	1	CbGaD
Drospirenone—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.00202	0.172	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.00178	0.152	CbGpPWpGaD
Drospirenone—Testolactone—CYP19A1—gestational diabetes	0.00117	0.127	CrCbGaD
Drospirenone—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.00108	0.0917	CbGpPWpGaD
Drospirenone—NR3C2—uterus—gestational diabetes	0.000847	0.0683	CbGeAlD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.000835	0.0712	CbGpPWpGaD
Drospirenone—NR3C2—adipose tissue—gestational diabetes	0.000829	0.0668	CbGeAlD
Drospirenone—PGR—uterus—gestational diabetes	0.000788	0.0635	CbGeAlD
Drospirenone—PGR—adipose tissue—gestational diabetes	0.00077	0.0621	CbGeAlD
Drospirenone—Testosterone Propionate—AR—gestational diabetes	0.000762	0.0826	CrCbGaD
Drospirenone—PGR—Ovarian Infertility Genes—CYP19A1—gestational diabetes	0.000759	0.0647	CbGpPWpGaD
Drospirenone—Spironolactone—SHBG—gestational diabetes	0.000737	0.0799	CrCbGaD
Drospirenone—Medroxyprogesterone Acetate—SHBG—gestational diabetes	0.000691	0.0749	CrCbGaD
Drospirenone—NR3C2—vagina—gestational diabetes	0.000689	0.0555	CbGeAlD
Drospirenone—Norethindrone—SHBG—gestational diabetes	0.000685	0.0742	CrCbGaD
Drospirenone—Methyltestosterone—SHBG—gestational diabetes	0.00065	0.0705	CrCbGaD
Drospirenone—Spironolactone—AR—gestational diabetes	0.000647	0.0701	CrCbGaD
Drospirenone—PGR—Nuclear Receptors—AR—gestational diabetes	0.000644	0.0549	CbGpPWpGaD
Drospirenone—PGR—vagina—gestational diabetes	0.00064	0.0516	CbGeAlD
Drospirenone—NR3C2—head—gestational diabetes	0.000636	0.0513	CbGeAlD
Drospirenone—AR—uterus—gestational diabetes	0.000628	0.0506	CbGeAlD
Drospirenone—AR—adipose tissue—gestational diabetes	0.000614	0.0495	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—AR—gestational diabetes	0.000606	0.0657	CrCbGaD
Drospirenone—PTGS2—islet of Langerhans—gestational diabetes	0.000603	0.0486	CbGeAlD
Drospirenone—PGR—head—gestational diabetes	0.000592	0.0477	CbGeAlD
Drospirenone—PTGS2—embryo—gestational diabetes	0.000583	0.047	CbGeAlD
Drospirenone—Methyltestosterone—AR—gestational diabetes	0.00057	0.0618	CrCbGaD
Drospirenone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—gestational diabetes	0.000561	0.0478	CbGpPWpGaD
Drospirenone—BCHE—uterus—gestational diabetes	0.000511	0.0412	CbGeAlD
Drospirenone—AR—vagina—gestational diabetes	0.00051	0.0411	CbGeAlD
Drospirenone—PGR—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.000509	0.0434	CbGpPWpGaD
Drospirenone—BCHE—adipose tissue—gestational diabetes	0.000499	0.0403	CbGeAlD
Drospirenone—Hydrocortisone—SHBG—gestational diabetes	0.00049	0.0531	CrCbGaD
Drospirenone—Methyltestosterone—CYP19A1—gestational diabetes	0.000477	0.0517	CrCbGaD
Drospirenone—AR—head—gestational diabetes	0.000471	0.038	CbGeAlD
Drospirenone—BCHE—vagina—gestational diabetes	0.000415	0.0335	CbGeAlD
Drospirenone—Progesterone—SHBG—gestational diabetes	0.000399	0.0433	CrCbGaD
Drospirenone—PTGS2—uterus—gestational diabetes	0.000393	0.0317	CbGeAlD
Drospirenone—PTGS2—adipose tissue—gestational diabetes	0.000385	0.031	CbGeAlD
Drospirenone—BCHE—head—gestational diabetes	0.000383	0.0309	CbGeAlD
Drospirenone—Testosterone—SHBG—gestational diabetes	0.000377	0.0409	CrCbGaD
Drospirenone—Progesterone—AR—gestational diabetes	0.00035	0.0379	CrCbGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.000331	0.0283	CbGpPWpGaD
Drospirenone—Testosterone—AR—gestational diabetes	0.000331	0.0359	CrCbGaD
Drospirenone—PTGS2—vagina—gestational diabetes	0.00032	0.0258	CbGeAlD
Drospirenone—PTGS2—head—gestational diabetes	0.000295	0.0238	CbGeAlD
Drospirenone—BCHE—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00028	0.0239	CbGpPWpGaD
Drospirenone—Testosterone—CYP19A1—gestational diabetes	0.000277	0.03	CrCbGaD
Drospirenone—AR—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000223	0.019	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—GLS2—gestational diabetes	0.000215	0.0183	CbGpPWpGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000206	0.0175	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000167	0.0143	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.000163	0.0139	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—LEP—gestational diabetes	0.000155	0.0132	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—AR—gestational diabetes	0.000144	0.0123	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—FGF2—gestational diabetes	0.000116	0.00989	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—AR—gestational diabetes	8.78e-05	0.00749	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	8.19e-05	0.00698	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.05e-05	0.00686	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	7.75e-05	0.00661	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	7.53e-05	0.00642	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	7.36e-05	0.00628	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AR—gestational diabetes	6.94e-05	0.00592	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GGCT—gestational diabetes	6.18e-05	0.00527	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEPR—gestational diabetes	5.63e-05	0.0048	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GLS2—gestational diabetes	5.4e-05	0.00461	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—gestational diabetes	5.27e-05	0.00449	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.83e-05	0.00412	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	4.79e-05	0.00408	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.48e-05	0.00382	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTNR1B—gestational diabetes	4.45e-05	0.0038	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RBP4—gestational diabetes	4.34e-05	0.0037	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GGCT—gestational diabetes	4.26e-05	0.00363	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	4.23e-05	0.00361	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AR—gestational diabetes	4.23e-05	0.00361	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	3.79e-05	0.00323	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GLS2—gestational diabetes	3.72e-05	0.00317	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.33e-05	0.00284	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NAMPT—gestational diabetes	2.96e-05	0.00252	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCK—gestational diabetes	2.94e-05	0.00251	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LEP—gestational diabetes	2.92e-05	0.00249	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RBP4—gestational diabetes	2.71e-05	0.00231	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.58e-05	0.0022	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NAMPT—gestational diabetes	2.43e-05	0.00208	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GCK—gestational diabetes	2.42e-05	0.00206	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—gestational diabetes	2.15e-05	0.00183	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NAMPT—gestational diabetes	2.04e-05	0.00174	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCK—gestational diabetes	2.03e-05	0.00173	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—gestational diabetes	1.98e-05	0.00169	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—gestational diabetes	1.5e-05	0.00128	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—gestational diabetes	1.48e-05	0.00126	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—gestational diabetes	9.4e-06	0.000801	CbGpPWpGaD
